Last updated on July 2014

A randomized, placebo controlled clinical trial to evaluate cardiovascular outcomes after treatment with exenatide once weekly in patients with type 2 diabetes mellitus. EXSCEL Trial, Protocol BCB109.


Brief description of study

A randomized, placebo controlled clinical trial to evaluate cardiovascular outcomes after treatment with exenatide once weekly in patients with type 2 diabetes mellitus. EXSCEL Trial, Protocol BCB109.

Detailed Study Description

The primary objective of this study will be to evaluate the effect of EQW, used in addition to the current usual care for glycemic control, on major macrovascular events when administered to patients with type 2 diabetes.

Clinical Study Identifier: TX138727

Find a site near you

Start Over

Chase Medical Research, LLC

500 Chase Parkway, 3rd floor Waterbury, CT USA
  Connect »

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.